Effect of Anti-IL5, Anti-IL5R, Anti-IL13 Therapy on Asthma Exacerbations: A Network Meta-analysis

被引：0
|
作者：
Richard P. Ramonell
Imran H. Iftikhar
机构：
[1] Emory University School of Medicine,Division of Pulmonary, Allergy, Critical Care & Sleep Medicine, Department of Medicine
来源：
Lung | 2020年 / 198卷
关键词：
Eosinophilic asthma; Benralizumab; Dupilumab; Mepolizumab; Reslizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：95 / 103
页数：8
相关论文
共 50 条
  • [41] Mepolizumab (Anti-IL5) and Exacerbation Frequency in Refractory Eosinophilic Asthma
    Haldar, P.
    Brightling, C.
    Hargadon, B.
    Gupta, S.
    Monteiro, W.
    Sousa, A.
    Marshall, R.
    Bradding, P.
    Green, R.
    Wardlaw, A.
    Pavord, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [42] Clinical and Lung Function Outcomes After Anti-IgE or Anti-IL5 Therapy in Severe Asthma
    AlShareef, Saad
    McDonald, Christine F.
    Lee, Joy
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 209 - 217
  • [43] Clinical Predictors of Treatment Failure to Anti-IL5 Therapy in Severe Eosinophilic Asthma
    Reihman, A. E.
    Liu, C.
    Cruse, M. H.
    Freid, L.
    Perez, N.
    Smith, V. L.
    Ferguson, L.
    Wechsler, M.
    Holguin, F.
    Manka, L.
    Sharma, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [44] Anti-IL-4R versus anti-IL-5/5R after anti-IL-5/5R failure in asthma: An emulated target trial
    Valery, Solene
    Simon-Tillaux, Noemie
    Devouassoux, Gilles
    Bonniaud, Philippe
    Beurnier, Antoine
    Boudjemaa, Amel
    Chenivesse, Cecile
    Bourdin, Arnaud
    Gauquelin, Lisa
    Guillo, Sylvie
    Taille, Camille
    Estellat, Candice
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 154 (04) : 922 - 932
  • [45] Indirect case-matched comparison of anti-IL4Rα versus anti-IL5Rα on airway hyperresponsiveness
    Chan, Rory
    Stewart, Kirsten
    Kuo, Chris RuiWen
    Lipworth, Brian
    ALLERGY, 2024, 79 (10) : 2873 - 2875
  • [46] First Outcomes of Anti-IL5 Biological Therapy in Patients with Severe Asthma in Croatia
    Rnjak, D.
    Stajduhar, A.
    Popovic-Grle, S.
    Ferara, N.
    Jelavic, I
    Lampalo, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [47] CHANGE IN FENO AS A BIOMARKER OF RESPONSE TO ANTI-IL5/5R THERAPIES IN SEVERE ASTHMA
    Hearn, A. P.
    Kavanagh, J. E.
    Dhariwal, J.
    Nanzer, A. M.
    Jackson, D. J.
    THORAX, 2022, 77 : A80 - A80
  • [48] Oral corticosteroid-sparing effects of Anti-IL5 and Anti-IL5 receptor treatments: A real-life study
    Bjerrum, A. S.
    Schmid, J.
    Skjold, T.
    ALLERGY, 2019, 74 : 36 - 37
  • [49] Use of CARAT© to assess anti-IL5/IL-5R impact in united airway disease
    Braganca, M.
    Placido, J. L.
    Amaral, L.
    ALLERGY, 2021, 76 : 172 - 173
  • [50] Arthritis, a new adverse effect of anti-IL5 biologics in severe asthma patients?
    Dupin, C.
    Morer, L.
    Phillips-Houlbracq, M.
    Deneuville, L.
    Lebrun, M.
    Tabeze, L.
    Juge, P.
    Taille, C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
12345